Rheumatoid Arthritis News

Although there are considerable intersectional inequalities among various age, gender and socioeconomic groups in the likelihood of diagnosis for osteoarthritis, gout and rheumatoid arthritis, no such inequalities were found for spondyloarthritis diagnosis, according to findings published in Arthritis Care & Research.

Treatment options for rheumatoid arthritis have changed drastically over the past 30 years, but some of today’s rheumatologists can still remember studying — and, more rarely, using — gold injections as a treatment for RA. A peek into the history of this treatment reveals a treasure trove of interesting ideas that connected various gold treatments to rheumatology, despite the often toxic results.

A strong association was observed between asthma and anti-citrullinated antibody elevation in a cohort of women with rheumatoid arthritis, and this association was independent of smoking, according to recent findings.

Officials from the Nebraska Department of Health and Human Services have issued a public health advisory following multiple reports of serious adverse events in patients who were treated with unapproved stem cell products, particularly those marketed as containing exosomes.

New treatments and trial designs, particularly focused on patients with refractory disease, remain among the top unmet needs in rheumatology in 2019, according to expert opinions culled from the Advances in Target Therapies annual meeting and published in the Annals of the Rheumatic Diseases.

The FDA has approved the fourth biosimilar to infliximab, infliximab-axxq, for all eligible indications of the biologic product.

When journalist Ben Hammersley coined the word “podcast” in 2004, he was attempting to put a name to the phenomenon resulting from the timely convergence of widely available MP3 player technology, inexpensive audio software and weblog culture — a renaissance of radio programs that could be downloaded and played at the listener’s convenience, anytime or anywhere.

Patients with inflammatory bowel disease, type 1 diabetes and venous thromboembolism have an increased risk for rheumatoid arthritis, which in turn increases the risk for cardiovascular disease, obstructive sleep apnea and — again — venous thromboembolism, according to data published in Mayo Clinic Proceedings.

Among a large cohort of patients with psoriasis, researchers found around 20% had an immune-mediated inflammatory disease develop before psoriasis onset and 14% had one develop after psoriasis onset, according to a study using data from the Danish National Patient Registry.

ATLANTA — Among patients with early rheumatoid arthritis who are positive for anti-citrullinated protein antibodies, and achieve remission with weekly treatments of abatacept and methotrexate, continuing this regimen resulted in the best remission maintenance, while tapering abatacept was associated with the greatest remission loss, according to data presented at ACR/ARP 2019.